119 related articles for article (PubMed ID: 1471384)
1. Repeated isovolemic large-volume erythrocytapheresis in the treatment of idiopathic hemochromatosis.
Kellner H; Zoller WG
Z Gastroenterol; 1992 Nov; 30(11):779-83. PubMed ID: 1471384
[TBL] [Abstract][Full Text] [Related]
2. [Large volume, isovolemic erythrocytapheresis in treatment of polycythemia vera. Effect of massive iron depletion of proliferation behavior of erythroid precursor cells (BFU-E)].
Liersch T; Vehmeyer K; Kaboth U
Med Klin (Munich); 1995 Jul; 90(7):390-7. PubMed ID: 7675003
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of erythrocytapheresis in idiopathic hemochromatosis. Report of 14 cases.
Conte D; Mandelli C; Cesana M; Ferrini R; Marconi M; Bianchi A
Int J Artif Organs; 1989 Jan; 12(1):59-62. PubMed ID: 2925263
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic erythrocytapheresis in the initial treatment of hereditary hemochromatosis.
Rehácek V; Bláha M; Jirousová H; Cernohorská J; Papousek P
Acta Medica (Hradec Kralove); 2012; 55(4):180-5. PubMed ID: 23631289
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of therapeutic erythrocytapheresis to achieve iron depletion in hereditary type 1 hemochromatosis: report of 30 cases].
Poullin P; Lefèvre PA
Transfus Clin Biol; 2011 Dec; 18(5-6):553-8. PubMed ID: 22019606
[TBL] [Abstract][Full Text] [Related]
6. Concomitant primary hemochromatosis and beta-thalassemia trait: iron depletion by erythrocytapheresis and desferrioxamine.
Cesana M; Mandelli C; Tiribelli C; Bianchi PA; Conte D
Am J Gastroenterol; 1989 Feb; 84(2):150-2. PubMed ID: 2916524
[TBL] [Abstract][Full Text] [Related]
7. In hereditary hemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebotomy.
Muncunill J; Vaquer P; Galmés A; Obrador A; Parera M; Bargay J; Besalduch J
J Clin Apher; 2002; 17(2):88-92. PubMed ID: 12210712
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis - A pilot study.
Rombout-Sestrienkova E; van Noord PA; van Deursen CT; Sybesma BJ; Nillesen-Meertens AE; Koek GH
Transfus Apher Sci; 2007 Jun; 36(3):261-7. PubMed ID: 17569592
[TBL] [Abstract][Full Text] [Related]
9. Erythrocytapheresis with recombinant human erythropoietin in hereditary hemochromatosis therapy: a new alternative.
Kohan A; Niborski R; Daruich J; Rey J; Bastos F; Amerise G; Herrera R; García M; Olivera W; Santarelli MT; Avalos JS; Findor J
Vox Sang; 2000; 79(1):40-5. PubMed ID: 10971213
[TBL] [Abstract][Full Text] [Related]
10. [Idiopathic hemochromatosis--diagnosis and therapy].
Schmidt U; Preu E; Tuschy U; Senf L; Herre K
Z Gesamte Inn Med; 1984 Apr; 39(8):152-60. PubMed ID: 6730591
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.
Franchini M; Gandini G; Veneri D; de Matteis G; Federici F; Solero P; Aprili G
Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247
[TBL] [Abstract][Full Text] [Related]
12. Hepatic iron clearance from serum in treated hemochromatosis.
Batey RG; Pettit JE; Nicholas AW; Sherlock S; Hoffbrand AV
Gastroenterology; 1978 Nov; 75(5):856-9. PubMed ID: 700326
[TBL] [Abstract][Full Text] [Related]
13. [Primary hemochromatosis in asymptomatic young patients].
Muñoz Sánchez MM; Núñez Martínez O; Torres Orgaz A; del Castillo Rueda A; de Portugal Alvarez J
An Med Interna; 2000 Jan; 17(1):9-12. PubMed ID: 10730398
[TBL] [Abstract][Full Text] [Related]
14. [Comparison between phlebotomy and erythrocytapheresis of iron overload in patients with HFE gene mutations].
Fernández-Mosteirín N; Salvador-Osuna C; García-Erce JA; Orna E; Pérez-Lungmus G; Giralt M
Med Clin (Barc); 2006 Sep; 127(11):409-12. PubMed ID: 17020684
[TBL] [Abstract][Full Text] [Related]
15. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
16. Hepatic iron concentration in hereditary hemochromatosis does not saturate or accurately predict phlebotomy requirements.
Olynyk JK; Luxon BA; Britton RS; Bacon BR
Am J Gastroenterol; 1998 Mar; 93(3):346-50. PubMed ID: 9517637
[TBL] [Abstract][Full Text] [Related]
17. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
Hicken BL; Tucker DC; Barton JC
Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
[TBL] [Abstract][Full Text] [Related]
18. The role of erythrocytapheresis in secondary erythrocytosis therapy.
Pollari G; Antonini V; Izzo A; Moreschini G; Serraino M; Tonelli V; D'Angiolino A; Migliaccio M
Clin Hemorheol Microcirc; 1999; 21(3-4):353-5. PubMed ID: 10711770
[TBL] [Abstract][Full Text] [Related]
19. Iron deficiency in the acute-phase reaction after open aortic surgery.
Solis JV; Portero JL; Diaz J; Garcia R; Ligero JM; Vazquez E; Lodeiro C; Ballesteros L
Vasc Endovascular Surg; 2006; 40(5):392-8. PubMed ID: 17038573
[TBL] [Abstract][Full Text] [Related]
20. Soluble transferrin receptor in hemochromatosis patients during phlebotomy therapy.
Piéroni L; Mekhloufi F; Thiolières JM; Hainque B; Herson S; Jardel C
Clin Chim Acta; 2005 Mar; 353(1-2):61-6. PubMed ID: 15698591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
